2021 annual financial data
Harvard Bioscience 2021 Operating cash flow margin
Direct answer
Operating cash flow margin was 1.06%.
Operating income was 2,066,000 USD and net income was -288,000 USD.
Operating cash flow was 1,262,000 USD.
Get free Harvard Bioscience email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 118,904,000 USD
- Operating income
- 2,066,000 USD
- Net income
- -288,000 USD
- Operating cash flow
- 1,262,000 USD